Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M B, Zingerenko"'
Publikováno v:
Experimental and Сlinical Urology. 13:30-35
Introduction. In the last 20 years there are an annual increase in the incidence of renal cell carcinoma (about 2%) in the world. According to the standards of international clinical guidelines for the treatment of renal cell carcinoma in stage T1 ki
Publikováno v:
Onkourologiâ, Vol 12, Iss 1, Pp 97-101 (2016)
Schwannoma is a benign tumor that grows from the Schwann cells forming the myelin sheath of peripheral nerves. The clinical manifestations are nonspecific and generally due to compression of the adjacent structures of a growing tumor. The location of
Publikováno v:
Endoskopicheskaya khirurgiya. 24:3
Autor:
L M, Gorilkovskiĭ, M B, Zingerenko
Publikováno v:
Urologiia (Moscow, Russia : 1999). (2)
The study of tulosine (tamsulosine) efficacy and safety was made in 92 patients with lower urinary tract symptoms (LUTS) due to prostatic adenoma (PA). Tulosine treatment relieved both obstructive and irritative symptoms, IPSS parameters improved by
Publikováno v:
Urologiia (Moscow, Russia : 1999). (6)
We studied efficacy ofsetegis in different doses for therapy of lower urinary tract symptoms in patients after transvesical adenomectomy (TVAE). The analysis of case histories of 41 patients after open TVPE for prostatic adenoma has shown that setegi
Autor:
L M, Gorilovskiĭ, M B, Zingerenko
Publikováno v:
Urologiia (Moscow, Russia : 1999). (6)